ReachRxResearch
Home
Research
Sign Up
Study limitation
Back to Research Hub
  1. Home
  2. Research Hub
  3. Study limitation

Atacicept in IgA Nephropathy — Phase 3 Trial Final Efficacy Analysis

Study limitation reported by the research below: “Funded by Vera Therapeutics (manufacturer of atacicept), introducing potential industry sponsorship bias.”

Papers